ND

Nandita Das Karmakar

Active Director Director DIN 10159185
DIN 10159185 First appointment May 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Nandita Das Karmakar

Data last updated:

Nandita Das Karmakar is a Director at Pharmajunction Private Limited (since 2023).

DIN 10159185
Primary Designation Director
First Appointment 11 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharmajunction Private Limited U47721WB2023PTC261928
Director11 May 20232023Active

Board colleagues of Nandita Das Karmakar

NameDINCompanyDesignation
Ratan Das10159186Pharmajunction Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pharmajunction Private Limited
Premium access

Shareholding and investment profile for Nandita Das Karmakar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nandita Das Karmakar

Nandita Das Karmakar currently holds 1 directorship: Pharmajunction Private Limited (Director, since 11 May 2023).

Nandita Das Karmakar was first appointed on 11 May 2023 as Director at Pharmajunction Private Limited.

The current boards of Nandita Das Karmakar's companies include Ratan Das (Pharmajunction Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available